NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search

Company Title Company Description City
Achelios Therapeutics Inc.

Achelios Therapeutics develops novel topical therapeutics for the treatment of inflammatory pain, including migraine and temporomandibular joint disorder pain.

Aestas Pharma Inc.

Asetas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced.

AimMax Therapeutics Inc.

AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners.

ALG Therapeutics LLC

ALG Therapeutics develops pharmaceutical products for pain disorders.

Chapel Hill
Aniluxx Biotechnology Inc.

Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain.

Arcato Laboratories Inc.

Arcato Laboratories develops specialty oral healthcare products including treatment for pain and discomfort from orthodontic appliances and post-surgical tooth extraction.

Balanced pHarma Inc.

Balanced pHarma is developing a pH-balanced dental anesthetic drug.

BioDelivery Sciences International Inc.

BioDelivery Sciences is a specialty pharmaceutical company with a focus in the areas of pain management and addiction. The company's lead products utilize a buccal film delivery system.

DMK Pharmaceuticals Inc.

DMK Pharmaceuticals develops small-molecule analgesics that have reduced side effects that are currently associated with marketed analgesics.

Holly Springs
Exodos Life Science Partners

Exodos Life Sciences advances product concepts through the 505(b)(2) process to early clinical proof-of-principle and sale. Exodus specializes in topical formulations for the treatment of Raynaud's Syndrome, cold sores and nail fungus.

Chapel Hill
Fortovia Therapeutics Inc.

Fortovia Therapeutics develops and commercializes oncology treatments and products for treating chemotherapy or radiotherapy side effects.


GSK develops and manufactures vaccines, medicines and consumer healthcare products, with a focus on science related to the immune system, use of genetics and advanced technologies.

Research Triangle Park
Isosceles Pharmaceuticals Inc.

Isosceles Pharmaceuticals is developing parenteral products for delivery of synthetic CBD to treat pain.

Kowa Research Institute Inc.

Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders.

Liquidia Technologies Inc.

Liquidia Technologies develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension and post-operative pain using its proprietary particle engineering technology.

Mallinckrodt Pharmaceuticals

Mallinckrodt manufactures acetaminophen, the active ingredient in Tylenol, at its pharmaceutical facility in Raleigh.

Migraine Solutions LLC

Migraine Solutions is developing Relaspen, an intra-nasal medical device which applies lidocaine directly to the SPG (Sphenopataline Ganglion) nerve, reducing migraines.

Mucodel Pharma LLC

Mucodel Pharma develops technologies for enhancing drug delivery via mucosal routes of administration. Its first candidate is a buccal gel for pain treatment and emergency treatment of opioid overdose.

NuBioPharma LLC

NuBioPharma develops and formulates novel liquid medications with child-friendly flavors for debilitating orphan diseases. Therapeutic areas include gout, pulmonary arterial hypertension and thrombocythemia.

Piedmont Animal Health Inc.

Piedmont Animal Health develops, licenses and markets animal health therapeutics with a focus on major companion animal categories.

Purdue Pharmaceuticals LP

Purdue Pharma develops and provides prescription medicines for the treatment of pain. The Wilson plant manufactures, packages and distributes oral solid-dose tablets and is the company's distribution center for prescription products.

Rilento Pharma LLC

Rilento Pharma is an early stage drug delivery company developing non-addictive oral surgery pain management technologies that are synchronized with the biologic process of wound healing.

Satsuma Pharmaceuticals Inc.

Satsuma Pharmaceuticals is developing best-in-class intranasal drug products to address the significant unmet medical needs of acute migraine sufferers.

Symberix Inc.

Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases as well as mitigate the lower GI side effects associated with various cancer, pain and immunosuppressive therapies.

Ternion Pharmaceuticals LLC

Ternion Pharmaceuticals is developing drugs for treatment of acute pain.

TRPblue Inc.

TRPblue is developing novel topical small-molecule treatments for chemotherapeutic-induced hand and foot neuropathy and atopic dermatitis and chronic itch.

Research Triangle Park
Vital Plan Inc.

Vital Plan formulates and produces therapeutically-dosed natural supplements and herbal therapies for managing fibromyalgia, Lyme disease, chronic fatigue and pain and hormonal imbalances.

Wilmington Pharmaceuticals LLC

Wilmington Pharmaceuticals develops fast-dissolving dosage forms for established medicines.